ALK-Abelló A/S
ALK-B
Rang in aandelen
#2357
ALK-Abelló A/S is a global leader in allergy solutions, with operations... ALK-Abelló A/S is a global leader in allergy solutions, with operations spanning Europe, North America, and other international regions. The company offers a comprehensive portfolio of treatments for allergic rhinitis and allergic asthma, featuring key products such as GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDACURE, and ITULAZAX. ALK-Abelló specializes in allergy immunotherapy, providing options like injections, sublingual drops, and tablets to address a wide range of sensitivities, including those to grass, ragweed, house dust mites, Japanese cedar, various tree pollens, and certain foods. Furthermore, the company engages with consumers through a digital healthcare ecosystem, a platform designed to connect with allergy sufferers early in their journey, offering tools, e-commerce solutions, and guidance to support and streamline access to immunotherapy. ALK-Abelló also provides essential diagnostic allergy services, including skin prick and blood tests, alongside emergency treatments such as intramuscular adrenaline injections for severe, life-threatening allergic reactions like anaphylaxis. The company was established in 1923 and is based in Hørsholm, Denmark.
Aandeelprijs
$37.79
Marktkapitalisatie
$8.38B
Verandering (1 dag)
4.29%
Verandering (1 jaar)
15.32%
Land
DK
Handel ALK-Abelló A/S (ALK-B)
Categorie
Healthcare
Operationele marge voor ALK-Abelló A/S (ALK-B)
Operationele marge op October 2026 TTM: 26.71%
Volgens de meest recente financiële rapporten en aandelenkoers van ALK-Abelló A/S is de huidige operationele marge (TTM) 26.71%. Eind 2023 had het bedrijf een operationele marge van 13.81%.
Geschiedenis van de operationele marge van ALK-Abelló A/S van 2004 tot 2026
Operationele marge aan het einde van elk jaar
| Jaar | Operationele Marge | Wijzigen |
|---|---|---|
| 2026 (TTM) | 26.71% | 35.58% |
| 2024 | 19.70% | 42.65% |
| 2023 | 13.81% | 32.53% |
| 2022 | 10.42% | 39.68% |
| 2021 | 7.46% | 73.49% |
| 2020 | 4.30% | -1,100.00% |
| 2019 | -0.43% | -86.93% |
| 2018 | -3.29% | 19.64% |
| 2017 | -2.75% | -117.25% |
| 2016 | 15.94% | 40.19% |
| 2015 | 11.37% | 4.79% |
| 2014 | 10.85% | 123.25% |
| 2013 | 4.86% | -3.38% |
| 2012 | 5.03% | -60.49% |
| 2011 | 12.73% | 43.19% |
| 2010 | 8.89% | -1.66% |
| 2009 | 9.04% | 35.53% |
| 2008 | 6.67% | -49.47% |
| 2007 | 13.20% | 270.79% |
| 2006 | 3.56% | 2,125.00% |
| 2005 | 0.16% | -97.72% |
| 2004 | 7.02% | 0.00% |
Operationele marge van vergelijkbare bedrijven of concurrenten
| Bedrijf | Operationele Marge | Verschil in operationele marge | Land |
|---|---|---|---|
| 38.59% | -98.56% |
US
|
|
| -149.01% | -105.58% |
US
|
|
| 25.57% | -99.04% |
AU
|
|
| 0.00% | - |
CH
|
|
| 28.81% | -98.92% |
NL
|
Wat is de Operationele marge van een bedrijf?
De Operationele marge is een belangrijke indicator om de winstgevendheid van een bedrijf te beoordelen. Hogere operationele marges zijn over het algemeen beter omdat ze aangeven dat een bedrijf zijn producten of diensten veel duurder kan verkopen dan de productiekosten. De Operationele marge wordt berekend door de winst van een bedrijf te delen door de omzet.